What is Solid Biosciences Inc.'s revenue?

Solid Biosciences Inc. (SLDB) generated $8.1M in revenue over the trailing twelve months, down 40.6% year over year.

Is Solid Biosciences Inc. profitable?

Solid Biosciences Inc. is not currently profitable: it reported a net loss of $191.8M over the trailing twelve months, a -1062.3% net margin.

What is Solid Biosciences Inc.'s earnings per share?

Solid Biosciences Inc.'s diluted EPS over the trailing twelve months is $-1.95.

Where does Solid Biosciences Inc.'s income statement data come from?

Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Solid Biosciences Inc. SLDB Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	——	——	——	——	——
Research and development	$46.14M+21.0%	$38.14M-1.9%	$38.86M+19.9%	$32.42M+4.9%	$30.91M+0.5%
General and administrative	$11.17M-0.9%	$11.27M+22.5%	$9.2M-0.9%	$9.28M+1.5%	$9.14M+0.1%
Restructuring charges	——	——	——	——	——
Other operating expenses	$57.31M+16.0%	$49.4M+2.8%	$48.06M+15.3%	$41.69M+4.1%	$40.05M+0.4%
Total operating expenses	$57.31M+16.0%	$49.4M+2.8%	$48.06M+15.3%	$41.69M+4.1%	$40.05M+0.4%
Operating income	-$57.31M-16.0%	-$49.4M-2.8%	-$48.06M-15.3%	-$41.69M-4.1%	-$40.05M-0.4%
Interest expense	——	$0+100%	-$336K-660%	$60K-11.8%	$68K-9.3%
Interest income	$2.06M+0.6%	$2.05M-20.6%	$2.59M-12.8%	$2.97M+29.0%	$2.3M+19.5%
Other income (expense), net	$571K—	$0-100%	$2.28M+3.1%	$2.21M+187%	$770K—
Net investment gains (losses)	-$1.65M+37.7%	-$2.65M-212%	-$850K+5.6%	-$900K+45.5%	-$1.65M-38.9%
Net income	-$56.74M-14.0%	-$49.79M-8.8%	-$45.78M-15.9%	-$39.48M-0.5%	-$39.28M+7.8%
Diluted earnings per share	-$0.52+1.9%	-$0.53-10.4%	-$0.48-14.3%	-$0.42+28.8%	-$0.59+42.2%
Basic earnings per share	-$0.52+1.9%	-$0.53-10.4%	-$0.48-14.3%	-$0.42+28.8%	-$0.59+42.2%
Weighted-average shares, diluted	109.8M+25.5%	87.5M-7.3%	94.4M+0.3%	94.1M+41.9%	66.3M+62.5%
Weighted-average shares, basic	109.8M+25.5%	87.5M-7.3%	94.4M+0.3%	94.1M+41.9%	66.3M+62.5%
Other income, net (Note 6)	$157K-28.3%	$219K+4.3%	$210K+1.4%	$207K+10.1%	$188K-5.5%
EBIT	-$57.31M-16.0%	-$49.4M-2.8%	-$48.06M-15.3%	-$41.69M-4.1%	-$40.05M-0.4%
EBITDA	-$56.91M-16.3%	-$48.94M-2.6%	-$47.68M-15.4%	-$41.31M-4.2%	-$39.65M-0.6%
EBITDA	-$56.91M-16.3%	-$48.94M-2.6%	-$47.68M-15.4%	-$41.31M-4.2%	-$39.65M-0.6%
EBIT	-$57.31M-16.0%	-$49.4M-2.8%	-$48.06M-15.3%	-$41.69M-4.1%	-$40.05M-0.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Solid Biosciences Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solid Biosciences Inc.'s revenue?: Solid Biosciences Inc. (SLDB) generated $8.1M in revenue over the trailing twelve months, down 40.6% year over year.
Is Solid Biosciences Inc. profitable?: Solid Biosciences Inc. is not currently profitable: it reported a net loss of $191.8M over the trailing twelve months, a -1062.3% net margin.
What is Solid Biosciences Inc.'s earnings per share?: Solid Biosciences Inc.'s diluted EPS over the trailing twelve months is $-1.95.
Where does Solid Biosciences Inc.'s income statement data come from?: Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.